Literature DB >> 6802330

Oral contraception in patients with hyperprolactinaemia.

P J Moult, J E Dacie, L H Rees, G M Besser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802330      PMCID: PMC1496298          DOI: 10.1136/bmj.284.6319.868

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  [The action of estrogens on hypophyseal adenoma in man. Histopathological documents in optical and electron microscopy and experimental contribution].

Authors:  F Peillon; E Vila-Porcile; L Olivier; J Racadot
Journal:  Ann Endocrinol (Paris)       Date:  1970 Mar-Apr       Impact factor: 2.478

3.  Outcome of pregnancy in women with pituitary adenoma.

Authors:  C Gemzell; C F Wang
Journal:  Fertil Steril       Date:  1979-04       Impact factor: 7.329

4.  Estrogen receptors in human pituitary adenomas.

Authors:  M F Pichon; D Bression; F Peillon; E Milgrom
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

  4 in total
  3 in total

Review 1.  Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

Review 2.  Prolactinomas.

Authors:  A Grossman; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

3.  Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy.

Authors:  M M Garcia; L P Kapcala
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.